ESKAPE Multipathogenic Nucleic Acid Test Kit (Fluorescent PCR Method)

Product Information

Product Requirements: iFIND ESKAPE

Detection Target: Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus

Cat. No. : 10T/box – 10210106A; 50T/box – 10210106B

This kit can quickly detect 6 common super-resistant bacteria in the hospital in sputum samples at one time, including Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus. Through specific drug resistance gene testing, strain identification and drug resistance analysis can be completed within 2 hours, providing accurate medication guidance for clinical practice. This test can effectively distinguish multidrug-resistant bacterial infections, help rational use of antibiotics, reduce abuse, and is an important tool for nosocomial infection control and clinical anti-infective treatment.

ESKAPE Multipathogenic Nucleic Acid Test Kit (Fluorescent PCR Method)

Current Status

Nosocomial drug-resistant bacterial infections have become a major threat to global public health. According to the World Health Organization (2023) report and the requirements of China's "Clinical Application Guidelines for Antibacterial Drugs (2023 Edition)", drug-resistant bacterial infections caused by 6 common pathogens such as Escherichia coli and Staphylococcus aureus account for more than 65% of nosocomial infections, with drug resistance rates continuing to rise and some strains showing resistance rates exceeding 50%. Traditional detection methods, which take 48-72 hours and fail to quickly identify drug resistance mechanisms, have severely restricted the efficiency of clinical diagnosis and treatment. To address this need, this product has been developed in strict compliance with national norms, aiming to break through existing technical bottlenecks and provide an innovative solution for the rapid diagnosis and precise medication of multidrug-resistant bacterial infections.

iFIND Solution

The iFIND ESKAPE Multipathogenic Nucleic Acid Test Kit (Fluorescent PCR Method) assay can simultaneously detect 6 of the most common nosocomial drug-resistant bacteria (covering over 65% of nosocomial drug-resistant bacterial infections), including Escherichia coli and Staphylococcus aureus. Using advanced multiplex PCR technology, it can complete bacterial species identification in only 2 hours, which is more than 24 times faster than traditional methods. Its rapid and accurate detection capability provides a scientific basis for the precise clinical use of antibiotics, effectively reducing empirical medication and lowering the risk of nosocomial infection transmission, fully complying with the regulatory requirements of the WHO and China for antibacterial drug management.